| | 68291-97-4 Basic information More.. |
| Product Name: | Zonisamide | | Synonyms: | BENZO[D]ISOXAZOL-3-YL-METHANESULFONAMIDE;1,2-BENZISOXAZOLE-3-METHANESULFONAMIDE;ZONISAMIDE;3-(sulfamoylmethyl)-1,2-benzisoxazole;ad-810;ci-912;exceglan;excegram | | CAS: | 68291-97-4 | | MF: | C8H8N2O3S | | MW: | 212.23 | | EINECS: | 614-395-8 | | Mol File: | 68291-97-4.mol |  |
Use
Zonisamide is a new generation of sulfonamide anticonvulsant that is primarily used as supplemental therapy in treatment of partial seizures in combination with other antiepileptic medications. Besides, it is approved to be applied as an adjunctive therapy in adults suffering from infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic, and generalized tonic clonic seizure. Recent studies have proved that zonisamide can acts as a migraine preventative medication and is effective in several cases of neuropathic pain. In an open-label trial, zonisamide shows positive effects on attenuating the symptoms of tardive dyskinesia.
Zonisamide is a broad-spectrum antiepileptic effective in the treatment of refractory seizures. In cultured spinal cord neurons, zonisamide blocks the sustained firing of action potentials induced by depolarizing steps of current injected across the membrane.
- Zonisamide
-
- 2026-09-18
- CAS:68291-97-4
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Zonisamide
-
- $40.00
- 2026-09-10
- CAS:68291-97-4
- Purity: 99.94%
- Supply Ability: 10g
- Zonisamide
-
- $1.10
- 2026-08-20
- CAS:68291-97-4
- Min. Order: 1g
- Purity: 99.0% Min
- Supply Ability: 100 Tons
|
|
68291-97-4
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|